论文部分内容阅读
目的:观察口服米索前列醇联合腹部B超在瘢痕子宫放置IUD的临床效果。方法:将160例要求放置IUD的患者随机分为实验组80例口服米索前列醇400μg 4 h后在腹部B超监视下开始手术,对照组80例术前不用任何药物直接进行手术。结果:宫颈软化率实验组83.75%,对照组10.00%,两组比较差异有统计学意义(P<0.05)。手术时间、手术成功率及术中出血量实验组均低于对照组,两组比较差异有统计学意义(P<0.05)。结论:口服米索前列醇400μg 4 h后可有效软化宫颈,联合腹部B超易于手术操作,术中出血少,值得临床推广。
Objective: To observe the clinical effect of oral misoprostol combined with abdominal B-ultrasonography in the placement of IUD in scarring uterus. Methods: One hundred and six patients with IUD were randomly divided into experimental group (n = 80), 80 cases of oral misoprostol (400 μg) for 4 hours, and then operated under abdominal B-ultrasound. In control group, 80 cases were operated without any drugs before surgery. Results: Cervical softening rate was 83.75% in the experimental group and 10.00% in the control group, with significant difference between the two groups (P <0.05). The operation time, operation success rate and intraoperative blood loss were lower in the experimental group than in the control group, with significant difference between the two groups (P <0.05). Conclusion: 400 μg oral misoprostol can soften cervix effectively after 4 h, and B-ultrasound combined with abdominal surgery is easy to operate, with less bleeding during operation and worthy of clinical promotion.